Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Says Supplement Adverse Event Under-Reporting Should Feed Growth

This article was originally published in The Tan Sheet

Executive Summary

FDA published a how-to guide to push dietary supplement firms toward tighter compliance with the requirement to submit serious adverse event reports to the agency.
Advertisement

Related Content

Supplements' Mandatory Adverse Event Reporting Portends Cosmetics' Potential Future
Mandatory AE Reporting In Supplement Space Offers Glimpse Of Possible Cosmetic Future
Supplement AER Under-Reporting Marks Tip Of Compliance Iceberg – FDA
Supplement AER Under-Reporting Marks Tip Of Compliance Iceberg – FDA
Supplement Industry Waits For “Friendlier” MedWatch Form
Supplement Industry Waits For “Friendlier” MedWatch Form
Final AER Guidance Requires Full Address, Recommends Prefatory Language
Final Guidance For Reporting Adverse Events Gets Serious On Definitions
Adverse Event Collection Expected To Be In Force By Christmas 2007
Adverse Event Collection Expected To Be In Force By Christmas 2007

Topics

Advertisement
UsernamePublicRestriction

Register

PS105252

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel